While the Philippines recently announced a large national ivermectin trial targeting early-onset COVID-19, another commercial study seeks to accelerate sufficient safety and efficacy data in…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.